Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2007 1
2008 1
2015 2
2016 6
2017 3
2018 5
2019 4
2020 5
2021 4
2022 4
2023 2
2024 8
2025 5
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Rationale for hypofractionation.
Hennequin C, Guillerm S, Quero L. Hennequin C, et al. Among authors: guillerm s. Cancer Radiother. 2019 Oct;23(6-7):500-502. doi: 10.1016/j.canrad.2019.07.156. Epub 2019 Aug 20. Cancer Radiother. 2019. PMID: 31444076 Review.
Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights.
Alsugair Z, Lépine C, Descotes F, Lanic MD, Pissaloux D, Tirode F, Lopez J, Céruse P, Philouze P, Fieux M, Wassef M, Baglin AC, Mihaela O, Castain C, Sudaka A, Uro-Coste E, Champagnac A, Costes-Martineau V, Laé M, Benzerdjeb N; REFCOR network*. Alsugair Z, et al. Hum Pathol. 2024 Oct;152:105633. doi: 10.1016/j.humpath.2024.105633. Epub 2024 Jul 30. Hum Pathol. 2024. PMID: 39089476 Free article.
Endoluminal brachytherapy: Bronchus and oesophagus.
Hennequin C, Guillerm S, Wong S, Quéro L. Hennequin C, et al. Among authors: guillerm s. Cancer Radiother. 2018 Jun;22(4):367-371. doi: 10.1016/j.canrad.2017.11.013. Epub 2018 May 30. Cancer Radiother. 2018. PMID: 29858135 Review.
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
Vera P, Giraud P, Hapdey S, Gouel P, Jan O, Le Roux P, Langlais A, Lévêque E, Le Tinier F, Olivier A, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boisselier P, Guillemard S, Salem N, Brenot-Rossi I, Garcia C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Loo M, Larrouy A, Ghazzar N, Chaumet-Riffaud P, Amour E, Zalcman G, Modzelewski R, Thureau S. Vera P, et al. Among authors: guillerm s. J Nucl Med. 2025 Apr 1;66(4):516-524. doi: 10.2967/jnumed.124.268499. J Nucl Med. 2025. PMID: 40015915 Clinical Trial.
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P. Vera P, et al. Among authors: guillerm s. Lancet Oncol. 2024 Sep;25(9):1176-1187. doi: 10.1016/S1470-2045(24)00320-6. Epub 2024 Aug 9. Lancet Oncol. 2024. PMID: 39134086 Clinical Trial.
Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma.
Quéro L, Labidi M, Bollet M, Bommier C, Guillerm S, Hennequin C, Thieblemont C. Quéro L, et al. Among authors: guillerm s. World J Gastrointest Oncol. 2021 Oct 15;13(10):1453-1465. doi: 10.4251/wjgo.v13.i10.1453. World J Gastrointest Oncol. 2021. PMID: 34721777 Free PMC article. Review.
Clinical, Dosimetric and Radiomic Features Predictive of Lung Toxicity After (Chemo)Radiotherapy.
Evin C, Razakamanantsoa L, Gardavaud F, Papillon L, Boulaala H, Ferrer L, Gallinato O, Colin T, Moussa SB, Harfouch Y, Foulquier JN, Guillerm S, Bibault JE, Huguet F, Wagner M, Rivin Del Campo E. Evin C, et al. Among authors: guillerm s. Clin Lung Cancer. 2025 Mar;26(2):93-103.e1. doi: 10.1016/j.cllc.2024.11.003. Epub 2024 Nov 20. Clin Lung Cancer. 2025. PMID: 39672787
[News in gastrointestinal radiotherapy: The esophageal cancer].
Quéro L, Besnard C, Guillerm S, Hennequin C. Quéro L, et al. Among authors: guillerm s. Cancer Radiother. 2022 Oct;26(6-7):875-878. doi: 10.1016/j.canrad.2022.06.004. Epub 2022 Aug 6. Cancer Radiother. 2022. PMID: 35941048 Review. French.
41 results